ABC Evening News for Monday, Feb 17, 1986
View other clips in this broadcast →
Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.
(Studio: Ted Koppel) Johnson and Johnson chairperson recalled describing cyanide contamination of company's Tylenol capsules as act of terrorism; Johnson and Johnson reported ending production of all nonprescription capsule prods.
(NYC: Bettina Gregory) Company's decision examined. [Chairperson James BURKE - explains move.] Other Johnson and Johnson prods. affected listed on screen, discussed. [Proprietary Association spokesperson Jack WALDEN - notes lack of such action by rest of pharmaceutical industry] Advantages of capsules explained. [Deputy FDA (Food and Drug Administration) commissioner John NORRIS - sees no justification beyond Johnson and Johnson's vol. action.] [Investment analyst David CROSSEN - thinks capsule industry as a whole is on the decline.] [Dr. Tim. JOHNSON - discusses medical effects of decision.] FBI and local police said inspecting Johnson and Johnson plant in which capsule that killed Diane Elsroth was manufactured
(Studio: Ted Koppel) [BURKE - discusses situation, company's decision today rather than after 1982 Chicago killings, caplet product.] "Nightline" announced.
(Studio: Ted Koppel) Item recapped at end of broadcast
Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.
Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:
If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.